Elsevier

Clinical Therapeutics

Volume 25, Issue 11, November 2003, Pages 2958-2971
Clinical Therapeutics

Original research
Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study

https://doi.org/10.1016/S0149-2918(03)80347-8Get rights and content

Abstract

Background: The cost of treating diabetes mellitus and its complications is high ($91.8 billion in the United States in 2002). It is important to understand predictors of adherence to therapy with different antidiabetic medications and to determine the relationships between adherence and health care service utilization in older adults (aged ≥65 years) with type 2 diabetes mellitus.

Objective: The aim of this study was to examine the relationship between self-reported health status data, subsequent antidiabetic medication adherence, and health care service utilization in older adults with type 2 diabetes mellitus in a managed care setting.

Methods: This was a longitudinal cohort study of older adults in the south-eastern United States with type 2 diabetes mellitus who completed a health status assessment, used antidiabetic medications, and were enrolled in a health maintenance organization (HMO) continuously for 1 to 5 years. The baseline assessment included questions related to demographics, health care service utilization in the year before enrollment, lifestyle, and quality of life. Demographic, clinical, and utilization-related economic variables were also retrieved from the administrative claims data of the patients' HMO. Prescription refill patterns were used to measure adherence. Associations were examined with a sequential, mixed-model, regression approach. Model appropriateness was tested via sensitivity analyses with logged and unlogged dependent variables.

Results: A total of 775 patients were included. Increased comorbidity severity and an emergency room visit during the year prior to enrollment in a Medicare HMO were independently associated with decreased antidiabetic medication possession ratios (MPRs) after enrollment. After controlling for type of medication therapy and other variables, increased antidiabetic MPR remained the strongest predictor of decreased total annual health care costs (8.6% to 28.9% decrease in annual costs with every 10% increase in MPR; P < 0.001). Adherence to anti-diabetic medications was a greater driver of cost reduction than other concurrent medications (eg, statins) in this population.

Conclusions: This study found strong associations between decreased anti-diabetic medication adherence and increased health care service utilization in older adults with type 2 diabetes mellitus in a managed care setting. Health status assessments completed at time of enrollment had the potential to identify enrollees with higher risk for both nonadherent behaviors and poor health-related outcomes.

References (29)

  • J. Dalewitz et al.

    Barriers to control of blood glucose in diabetes mellitus

    Am J Med Qual.

    (2000)
  • S.B. Johnson

    Methodological issues in diabetes research. Measuring adherence

    Diabetes Care

    (1992)
  • F. Venturini et al.

    Compliance with sulfonylureas in a health maintenance organization: A pharmacy record-based study

    Ann Pharmacother.

    (1999)
  • R. Balkrishnan et al.

    Self-reported health status, prophylactic medication use, and healthcare costs in older adults with asthma

    J Am Geriatr Soc.

    (2002)
  • Cited by (292)

    • Shared decision making, satisfaction with care and medication adherence among patients with diabetes

      2020, Patient Education and Counseling
      Citation Excerpt :

      Non-adherence has also been associated increased health care utilization and mortality in patients with diabetes [13]. Balkrishnan et al. estimated that a 10% increase in adherence to anti-diabetic medications would reduce cost of health care utilization by 8.6% in patients with diabetes [14]. Greenfield and colleagues reported that shared decision making has potential benefits of improving clinical outcomes, perceived health status and quality of life among patients with diabetes [15].

    View all citing articles on Scopus

    Dr. Balkrishnan is currently affiliated with the Division of Management and Policy Sciences, University of Texas School of Public Health, Houston, Texas.

    View full text